These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 31216439)
1. A brief history of antibody-based therapy. Alpaugh M; Cicchetti F Neurobiol Dis; 2019 Oct; 130():104504. PubMed ID: 31216439 [TBL] [Abstract][Full Text] [Related]
2. Active and passive immunotherapy for neurodegenerative disorders. Brody DL; Holtzman DM Annu Rev Neurosci; 2008; 31():175-93. PubMed ID: 18352830 [TBL] [Abstract][Full Text] [Related]
3. Active and passive immunization for cancer. Baxter D Hum Vaccin Immunother; 2014; 10(7):2123-9. PubMed ID: 25424829 [TBL] [Abstract][Full Text] [Related]
5. Maternal immunization to prevent infectious diseases in the neonate or infant. Insel RA; Amstey M; Woodin K; Pichichero M Int J Technol Assess Health Care; 1994; 10(1):143-53. PubMed ID: 8157447 [TBL] [Abstract][Full Text] [Related]
6. Immunotherapy against amyloid pathology in Alzheimer's disease. Galimberti D; Ghezzi L; Scarpini E J Neurol Sci; 2013 Oct; 333(1-2):50-4. PubMed ID: 23299047 [TBL] [Abstract][Full Text] [Related]
7. Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches. Kumar NN; Pizzo ME; Nehra G; Wilken-Resman B; Boroumand S; Thorne RG Bioconjug Chem; 2018 Dec; 29(12):3937-3966. PubMed ID: 30265523 [TBL] [Abstract][Full Text] [Related]
8. Overcoming the susceptibility gap between maternal antibody disappearance and auto-antibody production. Yosipovich R; Aizenshtein E; Shadmon R; Krispel S; Shuster E; Pitcovski J Vaccine; 2015 Jan; 33(3):472-8. PubMed ID: 25444785 [TBL] [Abstract][Full Text] [Related]
9. Gene transfer therapy for neurodegenerative disorders. Feigin A; Eidelberg D Mov Disord; 2007 Jul; 22(9):1223-8; quiz 1369. PubMed ID: 17393533 [TBL] [Abstract][Full Text] [Related]
10. Encapsulated cellular implants for recombinant protein delivery and therapeutic modulation of the immune system. Lathuilière A; Mach N; Schneider BL Int J Mol Sci; 2015 May; 16(5):10578-600. PubMed ID: 26006227 [TBL] [Abstract][Full Text] [Related]
12. Preventing sexual transmission of HSV and HIV: the challenge for active and passive immunization of mucosal surfaces. Zeitlin L; Palmer C; Whaley KJ Biotechnol Genet Eng Rev; 2002; 19():121-38. PubMed ID: 12520875 [No Abstract] [Full Text] [Related]
13. Passive and active immunization strategies against Clostridium difficile infections: state of the art. Mizrahi A; Collignon A; Péchiné S Anaerobe; 2014 Dec; 30():210-9. PubMed ID: 25079668 [TBL] [Abstract][Full Text] [Related]
14. Focus issue: signals to neurodegeneration. Wong W Sci Signal; 2009 Jul; 2(80):eg9. PubMed ID: 19622828 [TBL] [Abstract][Full Text] [Related]
15. Passive and active immunoprophylaxis of hepatitis B. Seeff LB; Koff RS Gastroenterology; 1984 May; 86(5 Pt 1):958-81. PubMed ID: 6231210 [No Abstract] [Full Text] [Related]
16. Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine. McConnell MJ; Pachón J Vaccine; 2010 Dec; 29(1):1-5. PubMed ID: 21044668 [TBL] [Abstract][Full Text] [Related]
17. Can we vaccinate against atherosclerosis? Chyu KY; Shah PK J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):77-82. PubMed ID: 24038015 [TBL] [Abstract][Full Text] [Related]